カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の多成分コデイン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Multi-ingredient Codeine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO20829）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO20829
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の多成分コデイン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

多成分コデイン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の多成分コデインの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

多成分コデイン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・15mg、30mg、60mg

用途別セグメントは次のように区分されます。
・麻薬性鎮痛剤、鎮咳剤、その他

世界の多成分コデイン市場の主要な市場プレーヤーは以下のとおりです。
・Taiji、Mallinckrodt、TEVA、Johnson & Johnson、Medreich、Sanofi Aventis、Cipla、Hikma、Pharmaceutical Associates、Novartis、Apotex、Mylan、Aristo Pharma GmbH、Lannett Company、Laboratoire Riva

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、多成分コデイン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な多成分コデインメーカーの企業概要、2019年～2022年までの多成分コデインの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な多成分コデインメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別多成分コデインの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの多成分コデインの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での多成分コデイン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および多成分コデインの産業チェーンを掲載しています。
・第13、14、15章では、多成分コデインの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 多成分コデインの概要
- 種類別分析（2017年vs2021年vs2028年）：15mg、30mg、60mg
- 用途別分析（2017年vs2021年vs2028年）：麻薬性鎮痛剤、鎮咳剤、その他
- 世界の多成分コデイン市場規模・予測
- 世界の多成分コデイン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Taiji、Mallinckrodt、TEVA、Johnson & Johnson、Medreich、Sanofi Aventis、Cipla、Hikma、Pharmaceutical Associates、Novartis、Apotex、Mylan、Aristo Pharma GmbH、Lannett Company、Laboratoire Riva
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：15mg、30mg、60mg
・用途別分析2017年-2028年：麻薬性鎮痛剤、鎮咳剤、その他
・多成分コデインの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・多成分コデインのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・多成分コデインのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・多成分コデインの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・多成分コデインの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Multi-ingredient Codeine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Multi-ingredient Codeine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Narcotic Analgesic accounting for % of the Multi-ingredient Codeine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 15mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Multi-ingredient Codeine include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, and Medreich, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Multi-ingredient Codeine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
15mg
30mg
60mg
Market segment by Application can be divided into
Narcotic Analgesic
Antitussive
Others
The key market players for global Multi-ingredient Codeine market are listed below:
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Multi-ingredient Codeine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Multi-ingredient Codeine, with price, sales, revenue and global market share of Multi-ingredient Codeine from 2019 to 2022.
Chapter 3, the Multi-ingredient Codeine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Multi-ingredient Codeine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Multi-ingredient Codeine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Multi-ingredient Codeine.
Chapter 13, 14, and 15, to describe Multi-ingredient Codeine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Multi-ingredient Codeine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Multi-ingredient Codeine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 15mg
1.2.3 30mg
1.2.4 60mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Multi-ingredient Codeine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Multi-ingredient Codeine Market Size & Forecast
1.4.1 Global Multi-ingredient Codeine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Multi-ingredient Codeine Sales in Volume (2017-2028)
1.4.3 Global Multi-ingredient Codeine Price (2017-2028)
1.5 Global Multi-ingredient Codeine Production Capacity Analysis
1.5.1 Global Multi-ingredient Codeine Total Production Capacity (2017-2028)
1.5.2 Global Multi-ingredient Codeine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Multi-ingredient Codeine Market Drivers
1.6.2 Multi-ingredient Codeine Market Restraints
1.6.3 Multi-ingredient Codeine Trends Analysis
2 Manufacturers Profiles
2.1 Taiji
2.1.1 Taiji Details
2.1.2 Taiji Major Business
2.1.3 Taiji Multi-ingredient Codeine Product and Services
2.1.4 Taiji Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Mallinckrodt
2.2.1 Mallinckrodt Details
2.2.2 Mallinckrodt Major Business
2.2.3 Mallinckrodt Multi-ingredient Codeine Product and Services
2.2.4 Mallinckrodt Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 TEVA
2.3.1 TEVA Details
2.3.2 TEVA Major Business
2.3.3 TEVA Multi-ingredient Codeine Product and Services
2.3.4 TEVA Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Multi-ingredient Codeine Product and Services
2.4.4 Johnson & Johnson Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Medreich
2.5.1 Medreich Details
2.5.2 Medreich Major Business
2.5.3 Medreich Multi-ingredient Codeine Product and Services
2.5.4 Medreich Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi Aventis
2.6.1 Sanofi Aventis Details
2.6.2 Sanofi Aventis Major Business
2.6.3 Sanofi Aventis Multi-ingredient Codeine Product and Services
2.6.4 Sanofi Aventis Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Multi-ingredient Codeine Product and Services
2.7.4 Cipla Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hikma
2.8.1 Hikma Details
2.8.2 Hikma Major Business
2.8.3 Hikma Multi-ingredient Codeine Product and Services
2.8.4 Hikma Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pharmaceutical Associates
2.9.1 Pharmaceutical Associates Details
2.9.2 Pharmaceutical Associates Major Business
2.9.3 Pharmaceutical Associates Multi-ingredient Codeine Product and Services
2.9.4 Pharmaceutical Associates Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Multi-ingredient Codeine Product and Services
2.10.4 Novartis Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business
2.11.3 Apotex Multi-ingredient Codeine Product and Services
2.11.4 Apotex Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Mylan
2.12.1 Mylan Details
2.12.2 Mylan Major Business
2.12.3 Mylan Multi-ingredient Codeine Product and Services
2.12.4 Mylan Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Aristo Pharma GmbH
2.13.1 Aristo Pharma GmbH Details
2.13.2 Aristo Pharma GmbH Major Business
2.13.3 Aristo Pharma GmbH Multi-ingredient Codeine Product and Services
2.13.4 Aristo Pharma GmbH Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Lannett Company
2.14.1 Lannett Company Details
2.14.2 Lannett Company Major Business
2.14.3 Lannett Company Multi-ingredient Codeine Product and Services
2.14.4 Lannett Company Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Laboratoire Riva
2.15.1 Laboratoire Riva Details
2.15.2 Laboratoire Riva Major Business
2.15.3 Laboratoire Riva Multi-ingredient Codeine Product and Services
2.15.4 Laboratoire Riva Multi-ingredient Codeine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Multi-ingredient Codeine Breakdown Data by Manufacturer
3.1 Global Multi-ingredient Codeine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Multi-ingredient Codeine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Multi-ingredient Codeine
3.4 Market Concentration Rate
3.4.1 Top 3 Multi-ingredient Codeine Manufacturer Market Share in 2021
3.4.2 Top 6 Multi-ingredient Codeine Manufacturer Market Share in 2021
3.5 Global Multi-ingredient Codeine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Multi-ingredient Codeine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Multi-ingredient Codeine Market Size by Region
4.1.1 Global Multi-ingredient Codeine Sales in Volume by Region (2017-2028)
4.1.2 Global Multi-ingredient Codeine Revenue by Region (2017-2028)
4.2 North America Multi-ingredient Codeine Revenue (2017-2028)
4.3 Europe Multi-ingredient Codeine Revenue (2017-2028)
4.4 Asia-Pacific Multi-ingredient Codeine Revenue (2017-2028)
4.5 South America Multi-ingredient Codeine Revenue (2017-2028)
4.6 Middle East and Africa Multi-ingredient Codeine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Multi-ingredient Codeine Sales in Volume by Type (2017-2028)
5.2 Global Multi-ingredient Codeine Revenue by Type (2017-2028)
5.3 Global Multi-ingredient Codeine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Multi-ingredient Codeine Sales in Volume by Application (2017-2028)
6.2 Global Multi-ingredient Codeine Revenue by Application (2017-2028)
6.3 Global Multi-ingredient Codeine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Multi-ingredient Codeine Sales by Type (2017-2028)
7.2 North America Multi-ingredient Codeine Sales by Application (2017-2028)
7.3 North America Multi-ingredient Codeine Market Size by Country
7.3.1 North America Multi-ingredient Codeine Sales in Volume by Country (2017-2028)
7.3.2 North America Multi-ingredient Codeine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Multi-ingredient Codeine Sales by Type (2017-2028)
8.2 Europe Multi-ingredient Codeine Sales by Application (2017-2028)
8.3 Europe Multi-ingredient Codeine Market Size by Country
8.3.1 Europe Multi-ingredient Codeine Sales in Volume by Country (2017-2028)
8.3.2 Europe Multi-ingredient Codeine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Multi-ingredient Codeine Sales by Type (2017-2028)
9.2 Asia-Pacific Multi-ingredient Codeine Sales by Application (2017-2028)
9.3 Asia-Pacific Multi-ingredient Codeine Market Size by Region
9.3.1 Asia-Pacific Multi-ingredient Codeine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Multi-ingredient Codeine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Multi-ingredient Codeine Sales by Type (2017-2028)
10.2 South America Multi-ingredient Codeine Sales by Application (2017-2028)
10.3 South America Multi-ingredient Codeine Market Size by Country
10.3.1 South America Multi-ingredient Codeine Sales in Volume by Country (2017-2028)
10.3.2 South America Multi-ingredient Codeine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Multi-ingredient Codeine Sales by Type (2017-2028)
11.2 Middle East & Africa Multi-ingredient Codeine Sales by Application (2017-2028)
11.3 Middle East & Africa Multi-ingredient Codeine Market Size by Country
11.3.1 Middle East & Africa Multi-ingredient Codeine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Multi-ingredient Codeine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Multi-ingredient Codeine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Multi-ingredient Codeine
12.3 Multi-ingredient Codeine Production Process
12.4 Multi-ingredient Codeine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Multi-ingredient Codeine Typical Distributors
13.3 Multi-ingredient Codeine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Multi-ingredient Codeine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Multi-ingredient Codeine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Taiji Basic Information, Manufacturing Base and Competitors
Table 4. Taiji Major Business
Table 5. Taiji Multi-ingredient Codeine Product and Services
Table 6. Taiji Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 8. Mallinckrodt Major Business
Table 9. Mallinckrodt Multi-ingredient Codeine Product and Services
Table 10. Mallinckrodt Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. TEVA Basic Information, Manufacturing Base and Competitors
Table 12. TEVA Major Business
Table 13. TEVA Multi-ingredient Codeine Product and Services
Table 14. TEVA Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Multi-ingredient Codeine Product and Services
Table 18. Johnson & Johnson Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Medreich Basic Information, Manufacturing Base and Competitors
Table 20. Medreich Major Business
Table 21. Medreich Multi-ingredient Codeine Product and Services
Table 22. Medreich Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Aventis Major Business
Table 25. Sanofi Aventis Multi-ingredient Codeine Product and Services
Table 26. Sanofi Aventis Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Cipla Basic Information, Manufacturing Base and Competitors
Table 28. Cipla Major Business
Table 29. Cipla Multi-ingredient Codeine Product and Services
Table 30. Cipla Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Hikma Basic Information, Manufacturing Base and Competitors
Table 32. Hikma Major Business
Table 33. Hikma Multi-ingredient Codeine Product and Services
Table 34. Hikma Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pharmaceutical Associates Basic Information, Manufacturing Base and Competitors
Table 36. Pharmaceutical Associates Major Business
Table 37. Pharmaceutical Associates Multi-ingredient Codeine Product and Services
Table 38. Pharmaceutical Associates Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Novartis Basic Information, Manufacturing Base and Competitors
Table 40. Novartis Major Business
Table 41. Novartis Multi-ingredient Codeine Product and Services
Table 42. Novartis Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Apotex Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Major Business
Table 45. Apotex Multi-ingredient Codeine Product and Services
Table 46. Apotex Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Mylan Basic Information, Manufacturing Base and Competitors
Table 48. Mylan Major Business
Table 49. Mylan Multi-ingredient Codeine Product and Services
Table 50. Mylan Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Aristo Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 52. Aristo Pharma GmbH Major Business
Table 53. Aristo Pharma GmbH Multi-ingredient Codeine Product and Services
Table 54. Aristo Pharma GmbH Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 56. Lannett Company Major Business
Table 57. Lannett Company Multi-ingredient Codeine Product and Services
Table 58. Lannett Company Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Laboratoire Riva Basic Information, Manufacturing Base and Competitors
Table 60. Laboratoire Riva Major Business
Table 61. Laboratoire Riva Multi-ingredient Codeine Product and Services
Table 62. Laboratoire Riva Multi-ingredient Codeine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Multi-ingredient Codeine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Multi-ingredient Codeine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Multi-ingredient Codeine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Multi-ingredient Codeine Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Multi-ingredient Codeine Production Site of Key Manufacturer
Table 68. Multi-ingredient Codeine New Entrant and Capacity Expansion Plans
Table 69. Multi-ingredient Codeine Mergers & Acquisitions in the Past Five Years
Table 70. Global Multi-ingredient Codeine Sales by Region (2017-2022) & (K Units)
Table 71. Global Multi-ingredient Codeine Sales by Region (2023-2028) & (K Units)
Table 72. Global Multi-ingredient Codeine Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Multi-ingredient Codeine Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Multi-ingredient Codeine Sales by Type (2017-2022) & (K Units)
Table 75. Global Multi-ingredient Codeine Sales by Type (2023-2028) & (K Units)
Table 76. Global Multi-ingredient Codeine Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Multi-ingredient Codeine Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Multi-ingredient Codeine Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Multi-ingredient Codeine Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Multi-ingredient Codeine Sales by Application (2017-2022) & (K Units)
Table 81. Global Multi-ingredient Codeine Sales by Application (2023-2028) & (K Units)
Table 82. Global Multi-ingredient Codeine Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Multi-ingredient Codeine Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Multi-ingredient Codeine Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Multi-ingredient Codeine Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Multi-ingredient Codeine Sales by Country (2017-2022) & (K Units)
Table 87. North America Multi-ingredient Codeine Sales by Country (2023-2028) & (K Units)
Table 88. North America Multi-ingredient Codeine Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Multi-ingredient Codeine Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Multi-ingredient Codeine Sales by Type (2017-2022) & (K Units)
Table 91. North America Multi-ingredient Codeine Sales by Type (2023-2028) & (K Units)
Table 92. North America Multi-ingredient Codeine Sales by Application (2017-2022) & (K Units)
Table 93. North America Multi-ingredient Codeine Sales by Application (2023-2028) & (K Units)
Table 94. Europe Multi-ingredient Codeine Sales by Country (2017-2022) & (K Units)
Table 95. Europe Multi-ingredient Codeine Sales by Country (2023-2028) & (K Units)
Table 96. Europe Multi-ingredient Codeine Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Multi-ingredient Codeine Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Multi-ingredient Codeine Sales by Type (2017-2022) & (K Units)
Table 99. Europe Multi-ingredient Codeine Sales by Type (2023-2028) & (K Units)
Table 100. Europe Multi-ingredient Codeine Sales by Application (2017-2022) & (K Units)
Table 101. Europe Multi-ingredient Codeine Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Multi-ingredient Codeine Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Multi-ingredient Codeine Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Multi-ingredient Codeine Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Multi-ingredient Codeine Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Multi-ingredient Codeine Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Multi-ingredient Codeine Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Multi-ingredient Codeine Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Multi-ingredient Codeine Sales by Application (2023-2028) & (K Units)
Table 110. South America Multi-ingredient Codeine Sales by Country (2017-2022) & (K Units)
Table 111. South America Multi-ingredient Codeine Sales by Country (2023-2028) & (K Units)
Table 112. South America Multi-ingredient Codeine Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Multi-ingredient Codeine Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Multi-ingredient Codeine Sales by Type (2017-2022) & (K Units)
Table 115. South America Multi-ingredient Codeine Sales by Type (2023-2028) & (K Units)
Table 116. South America Multi-ingredient Codeine Sales by Application (2017-2022) & (K Units)
Table 117. South America Multi-ingredient Codeine Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Multi-ingredient Codeine Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Multi-ingredient Codeine Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Multi-ingredient Codeine Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Multi-ingredient Codeine Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Multi-ingredient Codeine Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Multi-ingredient Codeine Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Multi-ingredient Codeine Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Multi-ingredient Codeine Sales by Application (2023-2028) & (K Units)
Table 126. Multi-ingredient Codeine Raw Material
Table 127. Key Manufacturers of Multi-ingredient Codeine Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Multi-ingredient Codeine Typical Distributors
Table 131. Multi-ingredient Codeine Typical Customers
List of Figures
Figure 1. Multi-ingredient Codeine Picture
Figure 2. Global Multi-ingredient Codeine Revenue Market Share by Type in 2021
Figure 3. 15mg
Figure 4. 30mg
Figure 5. 60mg
Figure 6. Global Multi-ingredient Codeine Revenue Market Share by Application in 2021
Figure 7. Narcotic Analgesic
Figure 8. Antitussive
Figure 9. Others
Figure 10. Global Multi-ingredient Codeine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Multi-ingredient Codeine Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Multi-ingredient Codeine Sales (2017-2028) & (K Units)
Figure 13. Global Multi-ingredient Codeine Price (2017-2028) & (US$/Unit)
Figure 14. Global Multi-ingredient Codeine Production Capacity (2017-2028) & (K Units)
Figure 15. Global Multi-ingredient Codeine Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Multi-ingredient Codeine Market Drivers
Figure 17. Multi-ingredient Codeine Market Restraints
Figure 18. Multi-ingredient Codeine Market Trends
Figure 19. Global Multi-ingredient Codeine Sales Market Share by Manufacturer in 2021
Figure 20. Global Multi-ingredient Codeine Revenue Market Share by Manufacturer in 2021
Figure 21. Multi-ingredient Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Multi-ingredient Codeine Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Multi-ingredient Codeine Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Multi-ingredient Codeine Sales Market Share by Region (2017-2028)
Figure 25. Global Multi-ingredient Codeine Revenue Market Share by Region (2017-2028)
Figure 26. North America Multi-ingredient Codeine Revenue (2017-2028) & (USD Million)
Figure 27. Europe Multi-ingredient Codeine Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Multi-ingredient Codeine Revenue (2017-2028) & (USD Million)
Figure 29. South America Multi-ingredient Codeine Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Multi-ingredient Codeine Revenue (2017-2028) & (USD Million)
Figure 31. Global Multi-ingredient Codeine Sales Market Share by Type (2017-2028)
Figure 32. Global Multi-ingredient Codeine Revenue Market Share by Type (2017-2028)
Figure 33. Global Multi-ingredient Codeine Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Multi-ingredient Codeine Sales Market Share by Application (2017-2028)
Figure 35. Global Multi-ingredient Codeine Revenue Market Share by Application (2017-2028)
Figure 36. Global Multi-ingredient Codeine Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Multi-ingredient Codeine Sales Market Share by Type (2017-2028)
Figure 38. North America Multi-ingredient Codeine Sales Market Share by Application (2017-2028)
Figure 39. North America Multi-ingredient Codeine Sales Market Share by Country (2017-2028)
Figure 40. North America Multi-ingredient Codeine Revenue Market Share by Country (2017-2028)
Figure 41. United States Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Multi-ingredient Codeine Sales Market Share by Type (2017-2028)
Figure 45. Europe Multi-ingredient Codeine Sales Market Share by Application (2017-2028)
Figure 46. Europe Multi-ingredient Codeine Sales Market Share by Country (2017-2028)
Figure 47. Europe Multi-ingredient Codeine Revenue Market Share by Country (2017-2028)
Figure 48. Germany Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Multi-ingredient Codeine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Multi-ingredient Codeine Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Multi-ingredient Codeine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Multi-ingredient Codeine Revenue Market Share by Region (2017-2028)
Figure 57. China Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Multi-ingredient Codeine Sales Market Share by Type (2017-2028)
Figure 64. South America Multi-ingredient Codeine Sales Market Share by Application (2017-2028)
Figure 65. South America Multi-ingredient Codeine Sales Market Share by Country (2017-2028)
Figure 66. South America Multi-ingredient Codeine Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Multi-ingredient Codeine Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Multi-ingredient Codeine Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Multi-ingredient Codeine Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Multi-ingredient Codeine Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Multi-ingredient Codeine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Multi-ingredient Codeine in 2021
Figure 78. Manufacturing Process Analysis of Multi-ingredient Codeine
Figure 79. Multi-ingredient Codeine Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 単一成分コデインのグローバル市場展望 2023年-2029年：普通錠、徐放錠
  • 世界の単一成分コデイン市場2022年：市場規模予測（～2028年）
  • 世界の天然成分防虫剤市場2022年：市場規模予測（～2028年）
  • 世界の抗生物質医薬品有効成分(API)市場2022年：市場規模予測（～2028年）
  • 世界の高繊維飼料成分市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO20829 )"世界の多成分コデイン市場2022年：市場規模予測（～2028年）" (英文：Global Multi-ingredient Codeine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。